Development of a paper-based lateral flow prothrombin assay.


Journal

Analytical methods : advancing methods and applications
ISSN: 1759-9679
Titre abrégé: Anal Methods
Pays: England
ID NLM: 101519733

Informations de publication

Date de publication:
06 Oct 2022
Historique:
pubmed: 2 9 2022
medline: 12 10 2022
entrez: 1 9 2022
Statut: epublish

Résumé

Disorders of haemostasis result in both excessive bleeding and clotting and are a major global cause of morbidity and mortality, particularly in the developing world. A small number of simple tests can be used to screen and monitor for such dysfunctions, one of which is the prothrombin time (PT) test and associated International Normalisation Ratio (INR). PT/INR is routine in hospital laboratories in developed countries, and can also be performed using point-of-care instruments. However, neither of these approaches is appropriate in low-resource settings. Significant interest has grown in paper-based devices to form the basis of simple and low-cost assays that may have the potential for application in such environments. This study describes the development of a simple, low-cost, paper-based lateral flow prothrombin assay. The assay employed wax printing on chromatography paper to define test channels, with deposition of thromboplastin reagent and calcium chloride onto the resulting strips. These were placed in a test housing and measurement of the flow rates of deposited plasma samples were performed in triplicate. The flow dynamics of the assay was optimised according to the type of paper substrate used, the nature and quantity of the thromboplastin reagent, the amount of calcium chloride required, and the volume of sample employed. An optimised assay configuration demonstrated a dynamic range of 6 mm between normal and factor-deficient plasmas. The assay showed good correlation with laboratory-based PT assay (Yumizen G200) in artificial plasmas in the 9.8 to 36 s range (

Identifiants

pubmed: 36048161
doi: 10.1039/d2ay00965j
doi:

Substances chimiques

Anticoagulants 0
Indicators and Reagents 0
Prothrombin 9001-26-7
Thromboplastin 9035-58-9
Calcium Chloride M4I0D6VV5M

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3718-3726

Auteurs

Jerro Saidykhan (J)

Department of Applied Sciences, Centre for Research in Biosciences (CRIB), University of the West of England, Coldharbour Lane, Bristol, BS16 1QY, UK. tony.killard@uwe.ac.uk.

Louise Pointon (L)

North Bristol NHS Trust, Southmead Hospital, Bristol, BS10 5NB, UK.

Stefano Cinti (S)

Department of Pharmacy, University of Naples "Federico II", Napoli 80131, Italy.

Jennifer E May (JE)

Department of Applied Sciences, Centre for Research in Biosciences (CRIB), University of the West of England, Coldharbour Lane, Bristol, BS16 1QY, UK. tony.killard@uwe.ac.uk.

Anthony J Killard (AJ)

Department of Applied Sciences, Centre for Research in Biosciences (CRIB), University of the West of England, Coldharbour Lane, Bristol, BS16 1QY, UK. tony.killard@uwe.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH